- Home
- INDP vs SBFM Comparison
INDP vs SBFM Comparison
Compare INDP & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- SBFM
- Stock Information
- Founded
- INDP 2000
- SBFM 2006
- Country
- INDP United States
- SBFM United States
- Employees
- INDP N/A
- SBFM N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- INDP Health Care
- SBFM Health Care
- Exchange
- INDP Nasdaq
- SBFM Nasdaq
- Market Cap
- INDP 6.0M
- SBFM 6.6M
- IPO Year
- INDP N/A
- SBFM N/A
- Fundamental
- Price
- INDP $2.40
- SBFM $1.47
- Analyst Decision
- INDP Strong Buy
- SBFM Strong Buy
- Analyst Count
- INDP 2
- SBFM 1
- Target Price
- INDP $238.00
- SBFM $15.00
- AVG Volume (30 Days)
- INDP 77.0K
- SBFM 47.3K
- Earning Date
- INDP 08-13-2025
- SBFM 11-04-2025
- Dividend Yield
- INDP N/A
- SBFM N/A
- EPS Growth
- INDP N/A
- SBFM N/A
- EPS
- INDP N/A
- SBFM N/A
- Revenue
- INDP N/A
- SBFM $36,341,741.00
- Revenue This Year
- INDP N/A
- SBFM $32.20
- Revenue Next Year
- INDP N/A
- SBFM $32.74
- P/E Ratio
- INDP N/A
- SBFM N/A
- Revenue Growth
- INDP N/A
- SBFM 19.22
- 52 Week Low
- INDP $2.47
- SBFM $1.17
- 52 Week High
- INDP $58.24
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- INDP 18.11
- SBFM 54.69
- Support Level
- INDP $6.26
- SBFM $1.35
- Resistance Level
- INDP $6.65
- SBFM $1.45
- Average True Range (ATR)
- INDP 0.69
- SBFM 0.07
- MACD
- INDP -0.33
- SBFM 0.00
- Stochastic Oscillator
- INDP 1.86
- SBFM 72.22
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.